Eastman Chemical Company filings document regulatory disclosures for a global specialty materials issuer with publicly traded common stock and outstanding debt securities. Form 8-K reports furnish quarterly and annual operating results, including sales, EBIT, cash flow, segment performance, price-cost conditions, raw-material pressures and updates tied to specialty businesses and methanolysis assets.
Proxy materials describe director elections, board committee matters, executive compensation, say-on-pay voting and shareholder proposals. Other material-event filings record debt issuance under registration statements and indentures, officer and director changes, compensatory arrangements, common stock references and note terms, including interest, maturity and redemption provisions.
Eastman Chemical Company is offering $600,000,000 aggregate principal amount of 4.500% notes due February 20, 2031.
The notes pay interest at 4.500% semi-annually on February 20 and August 20, beginning August 20, 2026, and are unsecured obligations that will rank equally with Eastman’s other unsecured and unsubordinated debt. Eastman expects to receive approximately $593.7 million in net proceeds and intends to use them for general corporate purposes, including working capital, capital expenditures and potential repayment of indebtedness.
The indenture permits optional redemption prior to maturity at prescribed redemption prices and requires Eastman to offer to repurchase the notes at 101% of principal if a Change of Control Triggering Event occurs. The notes will not be listed on an exchange and have no established trading market.
Eastman Chemical Company plans an offering of new unsecured, unsubordinated senior notes under its existing shelf registration. The notes will pay fixed semi-annual interest and mature on a specified future date, with no sinking fund and minimum denominations of $2,000.
The notes may be redeemed early at Eastman’s option, with a make-whole premium before a specified par call date and at par thereafter. If a defined change of control triggering event occurs, holders can require Eastman to repurchase the notes at 101% of principal plus accrued interest.
The notes will rank equally with Eastman’s other unsecured, unsubordinated debt; as of December 31, 2025, this included approximately $4.8 billion of debt. They will be structurally subordinated to obligations of subsidiaries. Eastman expects to use net proceeds for general corporate purposes, including working capital, capital spending, debt repayment, and strategic initiatives.
Eastman Chemical executive Brad A. Lich reported an equity award of company stock. On February 11, 2026, the EVP & CCO acquired 18,861 shares of Eastman Chemical common stock at $0 per share as a grant based on performance for the three-year 2023–2025 period.
After this award, Lich beneficially owned 102,348 common shares directly, plus 2,594 shares indirectly through a 401(k) plan and 1,251 shares indirectly through an ESOP, reflecting his combined direct and plan-based holdings in Eastman Chemical.
McLain William Thomas Jr. reported acquisition or exercise transactions in a Form 4 filing for EMN. The filing lists transactions totaling 15,883 shares. Following the reported transactions, holdings were 69,784 shares.
Eastman Chemical executive Stephen G. Crawford received an equity award of company stock. On February 11, 2026, he acquired 12,133 shares of Eastman Chemical common stock at a price of $0 per share, reported as a grant or award tied to performance.
This award, based on the determination of performance shares earned for the three-year 2023–2025 period, increased his direct holdings to 72,434 common shares. He also reports indirect ownership through benefit and retirement plans: 459 shares by a 401(k) plan, 296 shares by his spouse in an ESOP, 1,134 shares by an ESOP, and 64 shares by his spouse in a 401(k) plan.
Stewart Michelle Renee reported acquisition or exercise transactions in this Form 4 filing.
Eastman Chemical Controller and Chief Accounting Officer Michelle Renee Stewart received an award of 3,309 shares of common stock on February 11, 2026 at a price of $0 per share. The award reflects the determination of performance shares earned for the three-year 2023–2025 performance period. Following this grant, she directly owns 8,272 Eastman Chemical common shares.
Costa Mark J reported acquisition or exercise transactions in a Form 4 filing for EMN. The filing lists transactions totaling 64,192 shares. Following the reported transactions, holdings were 523,189 shares.
Eastman Chemical executive Julie A. McAlindon reported an equity award of company stock. On February 11, 2026, she acquired 7,280 shares of Eastman Chemical common stock at a price of $0 per share, reported as a grant, award, or other acquisition.
The footnote explains this reflects the determination of performance shares earned for the three-year 2023–2025 performance period, meaning the award was tied to multi‑year performance goals. After this grant, McAlindon directly beneficially owned 20,011 common shares, and indirectly beneficially owned an additional 887 shares through an ESOP.
Caveness Michelle H reported acquisition or exercise transactions in a Form 4 filing for EMN. The filing lists transactions totaling 1,937 shares. Following the reported transactions, holdings were 8,183 shares.
Eastman Chemical executive Brian Travis Smith acquired 10,589 shares of common stock on February 11, 2026 through a performance award. The shares were granted at a price of $0 per share following the determination of performance shares earned for the 2023–2025 period.
After this award, Smith directly beneficially owns 27,321 shares of Eastman Chemical common stock.